{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T16:40:07Z","timestamp":1781800807504,"version":"3.54.5"},"reference-count":90,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.idc.2025.11.002","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T21:01:03Z","timestamp":1764709263000},"page":"165-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Navigating the Challenges in Staphylococcus aureus Bloodstream Infection"],"prefix":"10.1016","volume":"40","author":[{"given":"Hadar","family":"Mudrik-Zohar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean W.X.","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Y.C.","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.idc.2025.11.002_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00355-19","article-title":"The microbiology of bloodstream infection: 20-year trends from the SENTRY antimicrobial surveillance program","volume":"63","author":"Diekema","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.idc.2025.11.002_bib2","article-title":"Incidence trends and epidemiology of Staphylococcus aureus bacteremia: a systematic review of population-based studies","volume":"14","author":"Hindy","year":"2022","journal-title":"Cureus"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2025.11.002_bib3","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1093\/ofid\/ofy270","article-title":"Twenty-year trends in antimicrobial susceptibilities among Staphylococcus aureus from the SENTRY antimicrobial surveillance program","volume":"6","author":"Diekema","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2025.11.002_bib4","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cmi.2022.03.015","article-title":"Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis","volume":"28","author":"Bai","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.idc.2025.11.002_bib5","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jinf.2021.10.001","article-title":"Mortality in Staphylococcus aureus bacteraemia remains high despite adherence to quality indicators: secondary analysis of a prospective cohort study","volume":"83","author":"Willekens","year":"2021","journal-title":"J Infect"},{"issue":"13","key":"10.1016\/j.idc.2025.11.002_bib6","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.2014.9743","article-title":"Clinical management of Staphylococcus aureus bacteremia: a review","volume":"312","author":"Holland","year":"2014","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.idc.2025.11.002_bib7","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2025.11.002_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.amjmed.2022.09.017","article-title":"The golden grapes of wrath - staphylococcus aureus bacteremia: a clinical review","volume":"136","author":"Lam","year":"2023","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.idc.2025.11.002_bib9","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/cid\/ciad784","article-title":"The utility of risk factors to define complicated Staphylococcus aureus bacteremia in a setting with low methicillin-resistant S. aureus prevalence","volume":"78","author":"van der Vaart","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"17","key":"10.1016\/j.idc.2025.11.002_bib10","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1001\/archinte.163.17.2066","article-title":"Clinical identifiers of complicated Staphylococcus aureus bacteremia","volume":"163","author":"Fowler","year":"2003","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.idc.2025.11.002_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jinf.2022.10.042","article-title":"Redefining Staphylococcus aureus bacteremia: a structured approach guiding diagnostic and therapeutic management","volume":"86","author":"Kouijzer","year":"2023","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.idc.2025.11.002_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jinf.2015.09.037","article-title":"Infectious disease consultation for Staphylococcus aureus bacteremia - a systematic review and meta-analysis","volume":"72","author":"Vogel","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.idc.2025.11.002_bib13","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2025.4288","article-title":"Management of Staphylococcus aureus bacteremia: a review","author":"Tong","year":"2025","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.idc.2025.11.002_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2020.11.007","article-title":"Time to blood culture positivity in Staphylococcus aureus bacteraemia to determine risk of infective endocarditis","volume":"27","author":"Kahn","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.idc.2025.11.002_bib15","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/cid\/ciae628","article-title":"Ursing J. Time to Staphylococcus aureus blood culture positivity as a risk marker of infective endocarditis: a retrospective cohort study","volume":"80","author":"Str\u00f6mdahl","year":"2025","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2025.11.002_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa371","article-title":"Real-world time to positivity of 2 widely used commercial blood culture systems in patients with severe manifestations of sepsis: an analysis of the FABLED study","volume":"7","author":"Butler-Laporte","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2025.11.002_bib17","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.8079","article-title":"Interpreting blood culture results as early guidance for infective endocarditis","volume":"8","author":"Freling","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"12","key":"10.1016\/j.idc.2025.11.002_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac647","article-title":"Prevalence and mortality of infective endocarditis in community-acquired and healthcare-associated","volume":"9","author":"\u00d8stergaard","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2025.11.002_bib19","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1093\/jac\/dkac129","article-title":"Clinical prediction scores and the utility of time to blood culture positivity in stratifying the risk of infective endocarditis in Staphylococcus aureus bacteraemia","volume":"77","author":"Simos","year":"2022","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.idc.2025.11.002_bib20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/cid\/civ235","article-title":"Predicting risk of endocarditis using a clinical tool (PREDICT): scoring system to guide use of echocardiography in the management of Staphylococcus aureus bacteremia","volume":"61","author":"Palraj","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2025.11.002_bib21","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jinf.2016.02.003","article-title":"The VIRSTA score, a prediction score to estimate risk of infective endocarditis and determine priority for echocardiography in patients with Staphylococcus aureus bacteremia","volume":"72","author":"Tubiana","year":"2016","journal-title":"J Infect"},{"issue":"5","key":"10.1016\/j.idc.2025.11.002_bib22","doi-asserted-by":"crossref","first-page":"e1151","DOI":"10.1093\/cid\/ciaa1844","article-title":"Validation of VIRSTA and predicting risk of endocarditis using a clinical tool (PREDICT) scores to determine the priority of echocardiography in patients with Staphylococcus aureus bacteremia","volume":"73","author":"Peinado-Acevedo","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2025.11.002_bib23","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/cid\/ciab632","article-title":"Prediction rules for ruling out endocarditis in patients with Staphylococcus aureus bacteremia","volume":"74","author":"van der Vaart","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2025.11.002_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10096-015-2505-8","article-title":"Low rates of endocarditis in healthcare-associated Staphylococcus aureus bacteremia suggest that echocardiography might not always be required","volume":"35","author":"Barton","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2025.11.002_bib25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/MD.0b013e318294a710","article-title":"Echocardiography is dispensable in uncomplicated Staphylococcus aureus bacteremia","volume":"92","author":"Khatib","year":"2013","journal-title":"Medicine (Baltim)"},{"issue":"1","key":"10.1016\/j.idc.2025.11.002_bib26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/cid\/ciae187","article-title":"Low-risk Staphylococcus aureus bacteremia patients do not require routine diagnostic imaging: a multicenter, retrospective, cohort study","volume":"79","author":"Hendriks","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2025.11.002_bib27","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0025-6196(12)61788-1","article-title":"Transesophageal echocardiography","volume":"69","author":"Khandheria","year":"1994","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"10.1016\/j.idc.2025.11.002_bib28","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.echo.2017.03.007","article-title":"Diagnostic accuracy of transthoracic echocardiography for infective endocarditis findings using transesophageal echocardiography as the reference standard: a meta-analysis","volume":"30","author":"Bai","year":"2017","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.idc.2025.11.002_bib29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ahj.2023.03.004","article-title":"Meta-analysis assessing the sensitivity and specificity of 18F-FDG PET\/CT for the diagnosis of prosthetic valve endocarditis (PVE) using individual patient data (IPD)","volume":"261","author":"O'Gorman","year":"2023","journal-title":"Am Heart J"},{"issue":"7","key":"10.1016\/j.idc.2025.11.002_bib30","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.26366","article-title":"Guidelines for diagnosis and management of infective endocarditis in adults: a WikiGuidelines group consensus statement","volume":"6","author":"McDonald","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"15","key":"10.1016\/j.idc.2025.11.002_bib31","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","article-title":"Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American heart association","volume":"132","author":"Baddour","year":"2015","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.idc.2025.11.002_bib32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10096-006-0238-4","article-title":"Complicating infectious foci in patients with Staphylococcus aureus or streptococcus species bacteraemia","volume":"26","author":"Cuijpers","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2025.11.002_bib33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s44303-024-00036-0","article-title":"The role of [18F]FDG-PET\/CT in Staphylococcus aureus bacteremia: a clinical perspective","volume":"2","author":"Kouijzer","year":"2024","journal-title":"Npj Imaging"},{"issue":"11","key":"10.1016\/j.idc.2025.11.002_bib34","doi-asserted-by":"crossref","first-page":"e3859","DOI":"10.1093\/cid\/ciaa929","article-title":"Integration of FDG-PET\/CT in the diagnostic workup for Staphylococcus aureus bacteremia: a prospective interventional matched-cohort study","volume":"73","author":"Ghanem-Zoubi","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2025.11.002_bib35","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.2967\/jnumed.117.191981","article-title":"F-FDG PET\/CT optimizes treatment in","volume":"58","author":"Berrevoets","year":"2017","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.idc.2025.11.002_bib36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/cid\/ciad112","article-title":"Positive impact of [18F]FDG-PET\/CT on mortality in patients with Staphylococcus aureus bacteremia explained by immortal time bias","volume":"77","author":"van der Vaart","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2025.11.002_bib37","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10096-023-04557-1","article-title":"Predictors of mortality of Staphylococcus aureus bacteremia among patients hospitalized in a Swiss university hospital and the role of early source control; a retrospective cohort study","volume":"42","author":"Papadimitriou-Olivgeris","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2025.11.002_bib38","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S1473-3099(20)30447-3","article-title":"Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study","volume":"20","author":"Kuehl","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2025.11.002_bib39","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/cid\/ciz257","article-title":"Defining the breakpoint duration of Staphylococcus aureus bacteremia predictive of poor outcomes","volume":"70","author":"Minejima","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2025.11.002_bib40","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/cid\/civ308","article-title":"Comparative effectiveness of beta-lactams versus vancomycin for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections among 122 hospitals","volume":"61","author":"McDanel","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2025.11.002_bib41","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1086\/510386","article-title":"Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia","volume":"44","author":"Stryjewski","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2025.11.002_bib42","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.amjmed.2016.01.048","article-title":"Back to the future: penicillin-susceptible Staphylococcus aureus","volume":"129","author":"Cheng","year":"2016","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.idc.2025.11.002_bib43","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/23744235.2017.1405276","article-title":"Trends in incidence and resistance patterns of Staphylococcus aureus bacteremia","volume":"50","author":"Jokinen","year":"2018","journal-title":"Infect Dis (Lond)"},{"issue":"39","key":"10.1016\/j.idc.2025.11.002_bib44","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1093\/eurheartj\/ehad193","article-title":"2023 ESC guidelines for the management of endocarditis","volume":"44","author":"Delgado","year":"2023","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.idc.2025.11.002_bib45","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ijantimicag.2019.05.020","article-title":"Benzylpenicillin versus flucloxacillin for penicillin-susceptible Staphylococcus aureus bloodstream infections from a large retrospective cohort study","volume":"54","author":"Henderson","year":"2019","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.idc.2025.11.002_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2022.106567","article-title":"Treatment outcome with penicillin G or cloxacillin in penicillin-susceptible Staphylococcus aureus bacteraemia: a retrospective cohort study","volume":"59","author":"Hagstrand Aldman","year":"2022","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.idc.2025.11.002_bib47","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10096-021-04330-2","article-title":"Penicillin versus anti-staphylococcal beta-lactams for penicillin-susceptible Staphylococcus aureus blood stream infections: a retrospective cohort study","volume":"41","author":"Reynolds","year":"2022","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2025.11.002_bib48","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1093\/jac\/dkad263","article-title":"Treatment outcomes with benzylpenicillin and non-benzylpenicillin antibiotics, and the performance of the penicillin zone-edge test versus molecular detection of blaZ in penicillin-susceptible Staphylococcus aureus (PSSA) bacteraemia","volume":"78","author":"Mok","year":"2023","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.idc.2025.11.002_bib50","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/jac\/dkab069","article-title":"Effectiveness of vancomycin plus cloxacillin compared with vancomycin, cloxacillin and daptomycin single therapies in the treatment of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in a rabbit model of experimental endocarditis","volume":"76","author":"Casta\u00f1eda","year":"2021","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.idc.2025.11.002_bib51","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.02495-21","article-title":"Prevalence and characterization of the cefazolin inoculum effect in north American methicillin-susceptible Staphylococcus aureus isolates","volume":"60","author":"Dingle","year":"2022","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.idc.2025.11.002_bib52","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/jac\/dkaf093","article-title":"Validation of a modified rapid test to detect the cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus from bloodstream infections in hospitals from North and Latin America","volume":"80","author":"Gomez-Villegas","year":"2025","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.idc.2025.11.002_bib53","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/cid\/cix287","article-title":"Comparative effectiveness of cefazolin versus nafcillin or oxacillin for treatment of methicillin-susceptible Staphylococcus aureus infections complicated by bacteremia: a nationwide cohort study","volume":"65","author":"McDanel","year":"2017","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"7","key":"10.1016\/j.idc.2025.11.002_bib54","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.cmi.2019.03.010","article-title":"Cefazolin versus anti-staphylococcal penicillins for the treatment of patients with Staphylococcus aureus bacteraemia","volume":"25","author":"Weis","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"10.1016\/j.idc.2025.11.002_bib55","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.cmi.2025.04.045","article-title":"Cefazolin vs. antistaphylococcal penicillins for the treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a systematic review and meta-analysis","volume":"31","author":"Prosty","year":"2025","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.idc.2025.11.002_bib57","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fpubh.2014.00217","article-title":"Vancomycin revisited - 60 years later","volume":"2","author":"Rubinstein","year":"2014","journal-title":"Front Public Health"},{"issue":"4","key":"10.1016\/j.idc.2025.11.002_bib58","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/phar.2376","volume":"40","author":"Rybak","year":"2020","journal-title":"Pharmacotherapy"},{"issue":"8","key":"10.1016\/j.idc.2025.11.002_bib59","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/cid\/ciad363","article-title":"Global differences in the management of Staphylococcus aureus bacteremia: no international standard of care","volume":"77","author":"Westgeest","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2025.11.002_bib60","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus","volume":"355","author":"Fowler","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.idc.2025.11.002_bib61","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/jac\/dkn372","article-title":"Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates","volume":"62","author":"Rehm","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"15","key":"10.1016\/j.idc.2025.11.002_bib62","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1056\/NEJMoa2300220","article-title":"Ceftobiprole for treatment of complicated Staphylococcus aureus bacteremia","volume":"389","author":"Holland","year":"2023","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.idc.2025.11.002_bib63","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1808312","article-title":"Partial oral versus intravenous antibiotic treatment of endocarditis","volume":"380","author":"Iversen","year":"2019","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.idc.2025.11.002_bib64","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S1473-3099(23)00756-9","article-title":"Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial","volume":"24","author":"Kaasch","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2025.11.002_bib65","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0002-9343(96)00070-8","article-title":"Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy","volume":"101","author":"Heldman","year":"1996","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.idc.2025.11.002_bib66","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1086\/424506","article-title":"A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection","volume":"39","author":"Schrenzel","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2025.11.002_bib67","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/cid\/ciae476","article-title":"Oral versus intravenous antibiotic therapy for Staphylococcus aureus bacteremia or endocarditis: a systematic review and meta-analysis of randomized, controlled trials","volume":"80","author":"Mourad","year":"2025","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2025.11.002_bib68","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2025.12543","article-title":"Dalbavancin for treatment of Staphylococcus aureus bacteremia: the DOTS randomized clinical trial","author":"Turner","year":"2025","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.idc.2025.11.002_bib69","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.cmi.2019.07.019","article-title":"Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study","volume":"26","author":"Abbas","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.idc.2025.11.002_bib70","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/cid\/ciae281","article-title":"Distinct clinical endpoints of Staphylococcus aureus bacteraemia complicate assessment of outcome","volume":"79","author":"Russell","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2025.11.002_bib71","article-title":"Short-term versus usual-term antibiotic treatment for uncomplicated Staphylococcus aureus bacteremia: a systematic review and meta-analysis","volume":"11","author":"Grillo Perez","year":"2024","journal-title":"Ther Adv Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2025.11.002_bib72","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s13063-019-3357-9","article-title":"Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial","volume":"20","author":"Thorlacius-Ussing","year":"2019","journal-title":"Trials"},{"issue":"4","key":"10.1016\/j.idc.2025.11.002_bib73","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-068295","article-title":"Safe shortening of antibiotic treatment duration for complicated for complicated Staphylococcus aureus bacteraemia (SAFE trial): protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatment","volume":"13","author":"Buis","year":"2023","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.idc.2025.11.002_bib74","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz170","article-title":"Effect of clinically uninfected orthopedic implants and Pacemakers\/AICDs in low-risk Staphylococcus aureus bloodstream infection on crude mortality rate: a post hoc analysis of a large cohort study","volume":"6","author":"Kaasch","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2025.11.002_bib75","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/cid\/civ808","article-title":"Combination of vancomycin and \u03b2-Lactam therapy for methicillin-resistant Staphylococcus aureus bacteremia: a pilot multicenter randomized controlled trial","volume":"62","author":"Davis","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2025.11.002_bib76","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/jama.2020.0103","article-title":"Effect of vancomycin or daptomycin with vs without an antistaphylococcal \u03b2-Lactam on mortality, bacteremia, relapse, or treatment failure in patients with MRSA bacteremia: a randomized clinical trial","volume":"323","author":"Tong","year":"2020","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.idc.2025.11.002_bib77","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1093\/cid\/ciaa1000","article-title":"Adjunctive daptomycin in the treatment of methicillin-Susceptible Staphylococcus aureus bacteremia: a randomized, controlled trial","volume":"72","author":"Cheng","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2025.11.002_bib78","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1038\/s41591-023-02569-0","article-title":"Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial","volume":"29","author":"Grillo","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.idc.2025.11.002_bib79","article-title":"Adjunctive fosfomycin for the treatment of Staphylococcus aureus bacteremia: a pooled post-hoc analysis of individual participant data from two randomized trials","author":"Escrihuela-Vidal","year":"2025","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2025.11.002_bib80","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/cid\/ciaa1081","article-title":"Daptomycin plus fosfomycin versus daptomycin alone for methicillin-Resistant Staphylococcus aureus bacteremia and endocarditis: a randomized clinical trial","volume":"72","author":"Pujol","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"10121","key":"10.1016\/j.idc.2025.11.002_bib81","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0140-6736(17)32456-X","article-title":"Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Thwaites","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.idc.2025.11.002_bib82","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/cid\/ciae289","article-title":"Does adjunctive clindamycin have a role in Staphylococcus aureus bacteremia? A protocol for the adjunctive treatment domain of the Staphylococcus aureus network adaptive platform (SNAP) randomized controlled trial","volume":"79","author":"Anpalagan","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2025.11.002_bib83","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/cid\/ciac476","article-title":"The Staphylococcus aureus network adaptive platform trial protocol: new tools for an old foe","volume":"75","author":"Tong","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2025.11.002_bib85","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/cid\/ciz995","article-title":"Cefazolin and ertapenem salvage therapy rapidly clears persistent methicillin-susceptible Staphylococcus aureus bacteremia","volume":"71","author":"Ulloa","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2025.11.002_bib86","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1093\/jac\/dkae198","article-title":"Carbapenem combination therapy versus standard of care for persistent methicillin-susceptible Staphylococcus aureus bacteraemia","volume":"79","author":"Shah","year":"2024","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.idc.2025.11.002_bib87","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1513\/AnnalsATS.202207-644ED","article-title":"\u201cThe cold steel of a surgeon or some fool of a physician?\u201d: the debate continues","volume":"19","author":"Bedawi","year":"2022","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"10.1016\/j.idc.2025.11.002_bib88","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/cid\/ciae338","article-title":"Clinical subphenotypes of Staphylococcus aureus bacteremia","volume":"79","author":"Swets","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2025.11.002_bib89","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5354747","article-title":"Investigation of virulence genes of Staphylococcus aureus isolated from sterile body fluid samples and their correlation with clinical symptoms and outcomes","volume":"2021","author":"Lin","year":"2021","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"3","key":"10.1016\/j.idc.2025.11.002_bib90","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.rvsc.2008.01.010","article-title":"Bovine staphylococcus aureus: association of virulence genes, genotypes and clinical outcome","volume":"85","author":"Fournier","year":"2008","journal-title":"Res Vet Sci"},{"issue":"9","key":"10.1016\/j.idc.2025.11.002_bib91","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1128\/JCM.00905-08","article-title":"Associations between the genotypes of Staphylococcus aureus bloodstream isolates and clinical characteristics and outcomes of bacteremic patients","volume":"46","author":"Lalani","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"7","key":"10.1016\/j.idc.2025.11.002_bib92","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1248\/bpb.b16-00255","article-title":"Analysis of staphylococcal toxins and clinical outcomes of methicillin-resistant Staphylococcus aureus bacteremia","volume":"39","author":"Maeda","year":"2016","journal-title":"Biol Pharm Bull"},{"issue":"4","key":"10.1016\/j.idc.2025.11.002_bib93","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/jac\/dku475","article-title":"Community-associated MRSA strain ST72-SCCmecIV causing bloodstream infections: clinical outcomes and bacterial virulence factors","volume":"70","author":"Park","year":"2015","journal-title":"J Antimicrob Chemother"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552025000960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552025000960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T20:43:11Z","timestamp":1773780191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552025000960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0891552025000960"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2025.11.002","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Navigating the Challenges in Staphylococcus aureus Bloodstream Infection","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2025.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}